A detailed history of Coppell Advisory Solutions LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Coppell Advisory Solutions LLC holds 441 shares of LLY stock, worth $404,838. This represents 0.05% of its overall portfolio holdings.

Number of Shares
441
Previous 7 6200.0%
Holding current value
$404,838
Previous $2.56 Million 9937.8%
% of portfolio
0.05%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $227,932 - $268,702
434 Added 6200.0%
441 $257 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $17,388 - $23,972
-40 Reduced 85.11%
7 $2.56 Million
Q2 2023

Aug 17, 2023

BUY
$350.74 - $468.98 $16,484 - $22,042
47 New
47 $21.8 Million
Q1 2023

May 19, 2023

SELL
$310.63 - $364.82 $2,174 - $2,553
-7 Closed
0 $0
Q4 2022

May 19, 2023

BUY
$321.55 - $374.67 $2,250 - $2,622
7 New
7 $2.56 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $872B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Coppell Advisory Solutions LLC Portfolio

Follow Coppell Advisory Solutions LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coppell Advisory Solutions LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coppell Advisory Solutions LLC with notifications on news.